i got sucked in when the sp soared on the positive numbers a year ago and there was talk particularly of the bio merineux distribution agreement which the company said would drive strong sales growth.
the last company report was a stark contrast with little growth in continuing business segments and declining profit.
i cut some losses but am onto half my holdings as i think the reward here is higher than the risk medium term. sentiment has been poor but the selling has mostly dried up now, so it would be a smart time to enter (hardest time to buy but most orofitable time).
i suspect MHT will start to grow sales within the next 12mo if they promote it effectively and the blood products just need a few key new clients to grow profits off a low base.
the share buyback was poorly timed and i hope they have enough cash to avoid a CR but ultimately the reduced number of shares in issue will mean any bullish ultrend will be stronger.
my conviction is quite weak with this stock but it seems objectively its a hold, and if anything a better time technically and fundamentally to buy than to sell.
- Forums
- ASX - By Stock
- Ann: ITL Launches more Blood Sector Products
i got sucked in when the sp soared on the positive numbers a...
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)